Sustainability for better, safer and more affordable medicines
Our responsibilities as an organisation are to the patients and consumers we serve, our employees, the communities in which we operate and our shareholders.
As a socially responsible organisation, we aim to:
- attract and retain the best talent
- promote a safe and healthy work environment
- deal ethically and fairly with all stakeholders
- prevent or minimise any environmental impact
- encourage innovation in product design
- meet or exceed our statutory obligations and commitments
- deliver returns to our shareholders
At Mayne Pharma we are focused on delivering a healthier tomorrow. We believe that everyone deserves medicines that are better, safer and more affordable. That’s why our people are determined to create clever, innovative products and services for our changing world.
Our Values are:
Mayne Pharma has a 40-year track record of innovation and success in developing oral drug delivery systems. These technologies have been successfully commercialized in numerous products that continue to be marketed around the world including DORYX®, KAPANOL®, ERYC®, ASTRIX® and LOZANOC®/TOLSURA®.
Our product portfolio:
- US Products
- Australian Products
- Rest of World Products
Mayne Pharma is a developer, manufacturer and marketer of branded and generic pharmaceuticals with operations in Australia and US and also provides contract development and manufacturing services to clients worldwide.
Solid financial performance enables us to invest in our future growth and to continue to support communities through charitable donations. Our growth strategy and our investments are discussed in our financial results and reports each half year.
Research, education and training